Disclosure Of Interests In Other Entities [Text Block]

Pharming Group N.V. - Filing #5829944

Concept 2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2022-12-31
Disclosure of interests in other entities [text block]
Disclosure of interests in subsidiaries [text block]
Disclosure of subsidiaries [text block]
Disclosure of subsidiaries [abstract]
Disclosure of subsidiaries [line items]
Current assets
278,440,000 USD
316,342,000 USD
Non-current assets
121,545,000 USD
146,512,000 USD
Current liabilities
73,802,000 USD
77,968,000 USD
Non-current liabilities
105,122,000 USD
166,105,000 USD
Revenue
297,200,000 USD
245,316,000 USD
Profit (loss)
11,841,000 USD
USD
USD
USD
11,841,000 USD
USD
10,548,000 USD
USD
10,548,000 USD
USD
Comprehensive income
23,742,000 USD
USD
USD
10,346,000 USD
13,396,000 USD
USD
3,445,000 USD
USD
10,548,000 USD
7,103,000 USD
Disclosure of interests in associates [text block]
Disclosure of associates [text block]
Disclosure of associates [abstract]
Disclosure of associates [line items]
Other comprehensive income
11,901,000 USD
USD
USD
11,901,000 USD
USD
USD
7,103,000 USD
USD
USD
7,103,000 USD
Investments accounted for using equity method
466,000 USD
2,285,000 USD
Disclosure of interests in joint arrangements [text block]
Disclosure of joint ventures [text block]
Disclosure of joint ventures [abstract]
Disclosure of joint ventures [line items]
Cash and cash equivalents
54,944,000 USD
61,741,000 USD
207,342,000 USD
Tax expense (income)
3,349,000 USD
1,464,000 USD

Talk to a Data Expert

Have a question? We'll get back to you promptly.